Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07142720 · ClinicalTrials.gov registry record · NA
Rapid Effects on Antioxidant Status, Immune Alertness, and Regenerative Activity
A NA study, sponsored by Natural Immune Systems.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07142720 is a NA study that has completed, run by Natural Immune Systems. The registered enrollment target is 20 participants.
The verdict
NCT07142720, a NA study, has completed, sponsored by Natural Immune Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This clinical study aims at documenting rapid effects after consuming single doses of test product, when compared to consuming a placebo. A double-blind, placebo-controlled, cross-over study design will be used.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT A low dose of seaweed extract
- DIETARY_SUPPLEMENT A high dose of seaweed extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07142720
The ClinicalTrials.gov registry entry for NCT07142720 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natural Immune Systems, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07142720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07142720 about?
NCT07142720 is a clinical study titled "Rapid Effects on Antioxidant Status, Immune Alertness, and Regenerative Activity". This clinical study aims at documenting rapid effects after consuming single doses of test product, when compared to consuming a placebo. A double-blind, placebo-controlled, cross-over study design will be used.
What is the current status of trial NCT07142720?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-11-01. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT07142720?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), A low dose of seaweed extract (DIETARY_SUPPLEMENT), A high dose of seaweed extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07142720?
This trial is sponsored by Natural Immune Systems, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.